5.7. Immune system Flashcards

1
Q

What is a pathogen?

A

a disease-causing agent – can be viruses, bacteria, fungi, protoctists, animals, plants (only to other plants) – no Archeans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can pathogens be regarding their host “preferences”? give examples. How are those second diseases called in case of animals?

A

species-specific or can cross species barriers (changing their receptors to fit other cell glycoproteins) like rabies virus, SIV (HIV), tuberculosis, COVID-19…
Zoonosis is a disease that can be transmitted from an infected animal to a non-infected human

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Human immune system organs and tissues and their function

A

Immune cells develop in bone marrow (B-lymphocyte) and thymus (T-ly)
Lymph nodes strategically positioned to prevent the pathogens from entering the trunk where vital organs are situated
Tonsils
Spleen
Appendix (storage of immune cells/tissue at the appendix – impaired flow unlike in the rest of the long intestine, accumulation of pathogens)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Two immune systems:

A
  1. Innate/non-specific IS – 1st line of defense skin and mucous, 2nd line macrophages (phagocytes)
  2. Adaptive/specific IS (not inherited) 3rd line of defense mediated by T-ly and B-lymphocyte cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do skin and mucous prevent the entry of microbes

A

Epidermis (20-30 cells, physical barrier, carotin, dead cells, acidic) and dermis (thicker, tissue-specific STEM cells that renew skin, acidic due to sebum (produced by sebaceous gland, made of lactic and fatty acid)
Mucous membrane protects internal cavities that are exposed to the external environment, contains lysozyme that destroys the bacterial cell wall (peptidoglycan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

White blood cell types:

A
  • majority of leukocytes are outside of blood, in the lymph or interstitial fluid
    Neutrophils – phagocytes
    Monocytes (macrophages, phagocytes/phagocytic leukocytes) – cells in the interstitial space that recognize pathogens by their AG, perform phagocytosis (lysosome inside) and alarm the 3rd line of defense – move by amoebal movement (arms to swim)
    Eosinophil
    Basophil
    Lymphocytes (B and T cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Wound process:

A

Pathogens enter through skin
Leukocytes in blood recognize chemicals released by pathogens and injured cells
Leukocytes exit through capillary cell wall and follow chemical signals
At the site of damaged tissue, monocytes differentiate into macrophages and start phagocytosis
Eosinophils and neutrophils also release chemicals that digest pathogens (and phagocytosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phagocytosis process

A

Lysosome, vessel with pathogen, fuse
End products of digestion expelled by exocytosis except AG
AG displayed on the plasma membrane, connected to an MHCH protein (major human histocompatibility complex) – cell is turned into an antigen-presenting cell (APC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antigens function

A

Intramembrane protein
Basis for the distinction between self- and non-self cells is antigens (glycoproteins).
Structure genetically controlled so close relatives have more similar AGs
When a pathogen enters the body, AG is what the immune system reacts against

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RBC groups and antigens

A

Blood transfusion: immune response triggered by recognition of non-self AG on erythrocyte membrane
ABO: 0 (AG H, all RBC possess it), A (AG H + a sugar), B (AG H + an amine), AB (AG H, sugar and amine)
0 has anti-A and anti-B antibody, A only anti-B, B only anti-A, AB none – 0 is universal donor, AB universal acceptor – AB in the plasma
Rh: Rh+ (AG Rh), Rh-(don’t have AG Rh)
Rh+ has no AB, Rh- has anti-Rh AB
Rh AG developed only contact made with Rh+ and genetic potential for Rh-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antibodies structure and function

A

Immunoglobulins
Proteins that recognize and bind to specific AG on a pathogen – specific to only one AG (every human has millions of different types of lymphocytes)
Mobile and soluble unlike AG
4 polypeptide chains joined together (cystine by disulfide bridges) to form a Y-shaped structure with a constant and a variable region. The AG binding site is on the tips of variable regions (specific, unique a-a sequence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AB destroy pathogens by (3 ways):

A
  1. Neutralization – blocks viral binding sites and coats bacteria (membrane created)– prevents binding and thus replicating – marks it for phagocytosis
  2. Creating holes on the pathogen’s membrane
  3. Agglutination of microbes – marking them for destruction by making them larger and less mobile, easier target for phagocytes – one AB binds to AG of two pathogens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Immune response/AB production

A
  1. Phagocytes perform the phagocytosis
  2. AG presentation – APC created from phagocytic leukocyte
  3. Activation of helper T-ly – recognize and bind to AG on macrophage which activates it
  4. Activated T-helper activates B-ly cells to confirm AG’s presence, if the rsceptor on B-ly is complementary to the AG, B-ly is activated by cytokines from helper T-cell
  5. Activated B-ly creates either plasma cells (enlarged B-cell clones with an extensive rER to produce AB in order to fight the infection) or memory cells (stay the same and wait for another infection when they immediately react and proliferate and produce AB, without T-cells. The stronger the infection, the stronger the developed immunity (more memory cells) and they either last for a few years or forever)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is the secondary response different from the primary?

A

much faster and more intense because a large number of memory cells has remained after the 1st infection and they are capable of producing large amounts of AB very quickly when stimulated by an AG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are and what is the reason for the existence of polyclonal and monoclonal AB? Example of one (pregnancy kit).

A

Polyclonal – most pathogens have more than one AG, stimulat more than one type of lymphocyte and thus result in production of more than one AB – produced any time the infection is natural
Monoclonal – only possible by vaccination – basis for tests (COVID, pregnancy) and treatments (tetanus, venomous bite)
Test based on detecting the human chorionic gonadotropin (hCG) hormone (early pregnancy) – firstly, hCG joins with artificial monoclonal AB, if the hormone’s present, immobilized monoclonal AB inside the test join with it, the joining causes a change in color – the second window exists to ensure that the test works, third type of monoclonal AB joins with empty AB (after the first window)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How vaccination works

A

Immunization is the 1st exposure to a pathogen (AG) and triggers the primary immune response
Less pathogenicity: traditional – dead pathogen, weakened pathogen, AG only (B cells recognize AG and create memory cells) and advanced (COVID-19) – DNA or mRNA coding for a pathogen’s AG (body cells read the code and produce AG which get recognized by B-cells)

17
Q

Benefits/risks of vaccination

A

Benefits: disease eradication (smallpox), death rate and long-term disabilities reduced (blindness from rubella), reduced health-care costs, her immunity
Risks: reduced IS effectiveness, vaccine immunity sometimes less effective than natural

18
Q

Herd immunity

A

indirect protection from an infectious disease – when a significant proportion of the population has contracted a disease or been vaccinated – spread of disease impeded because encounters immune people – percentage of pop estimated by formula (1 – 1/R) * 100% where R is the average number of people that an infected person infects (depends on the disease)

19
Q

Blood clotting process:

A
  1. platelets and damaged tissue cells release clotting factors (proteins) into the plasma
  2. clotting factors activate the inactive form of prothrombin (enzyme) into thrombin
  3. thrombin turns soluble plasma protein fibrinogen into fibrous form fibrin (insoluble) and fibrin molecules bind together to form a mesh of fibers across the wound
  4. blood cells caught in the mash, form a clot – prevents further bleeding and pathogen entry
20
Q

AIDS and HIV

A

acquired immunodeficiency syndrome, caused by human immunodeficiency virus
infectious nature of AIDS through the transmission of HIV
loss of specific immunity, diseases cannot be resisted when a person is infected
variation in the way the disease manifests itself (two AIDS patients can be affected by different sets of diseases)

retrovirus that infects T-helper lymphocytes and disables AB production
transmitted in contact with the body fluids of an infected person (blood, semen, vaginal mucus, through the placenta)

21
Q

Antibiotics

A

antimicrobial (mostly antibacterial) chemicals
kill bacteria by impeding their DNA/protein/cell wall (e.g. penicillin) synthesis
from saprotrophic fungi (kill saprotrophic bacteria, compete for dead organic matter)
prescribed to treat bacterial infections, ineffective against viruses and eukaryotic cells

22
Q

Antibiotic resistance

A

happens between resistant strains are not killed by the antibiotic so they multiply and spread (natural selection) – multiple resistance is problematic (e.g. MRSA) – evolution of multiple antibiotic resistance happens rapidly because they can pass genes from one species to another and ARGs (antibiotic-resistance genes) remain in pathogenic bacteria if antibiotic is no longer used
avoiding increasing antibiotic resistance by:
prescribing antibiotics only for serious bacterial infections for min time, hospital staff maintains high standards of hygiene to prevent cross-infection, farmers avoid use of antibiotics in animal food, pharmaceutical companies develop new classes of antibiotics (none have been introduced since 1980s)